Fiche centre
Foothills Medical Centre
Calgary — Canada
Essais liés5clinical trials
VilleCalgarylocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03938987
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Ablation and Cementoplasty | Cancer | Non applicable | NCT04635137 | Ablation and Cementoplasty for Painful Bone Lesions | UNKNOWN |
| Active Colchicine | Maladie coronarienne | Phase 3 | NCT03310125 | Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) | COMPLETED |
| autologous CD19-directed chimeric antigen receptor (CAR) T-cells | SEP | Phase 1/2 | NCT03938987 | ACIT001/EXC002 — Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) | RECRUITING |
| PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® | Migraine | À vérifier | NCT02502123 | PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® | COMPLETED |
| Ocrelizumab | SEP | Phase 3 | NCT01194570 | ORATORIO — A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis | COMPLETED |